Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System
Therapeutic Innovation & Regulatory Science · 2023-07 · 57 (4) · 886-898
DOI: 10.1007/s43441-023-00514-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 27.04.2023. Verfasst von Binaya Sapkota und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Nobel College, Sinamangal, Kathmandu, Nepal. binaya@nobelcollege.edu.np. Hauptthemen laut MEDLINE: Pharmacovigilance, Health Personnel. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University.
Abstract (Originalsprache)
Materiovigilance (Mv) has the same purpose and approach in ensuring patient safety as pharmacovigilance but deals with medical devices associated with adverse events (MDAEs) and their monitoring. Mv has been instrumental in recalling many defective or malfunctioning devices based on their safety data. All MDAEs, such as critical or non-critical, known, or unknown, those with inadequate or incomplete specifications, and frequent or rare events should be reported and evaluated. Mv helps to improve medical devices’ design and efficiency profile and avoid device-related complications and associated failures. It alerts consumers and health professionals regarding counterfeit or substandard devices. Common events reported through Mv are device breakage and malfunction, entry- and exit-site infections, organ perforations or injuries, need for surgery and even death, and life cycle assessment of devices. Health authorities globally have developed reporting frameworks with timeframes for MDAEs, such as MedWatch in the USA, MedSafe in New Zealand, and others. Health professionals and consumers need to be made aware of the significance of Mv in ensuring the safe use of medical devices and getting familiar with the reporting procedures and action plans in case of a device-induced adverse event.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health Sciences, Nobel College, Sinamangal, Kathmandu, Nepal. binaya@nobelcollege.edu.np.
- Jeffrey Sachs Center On Sustainable Development, Sunway University, Sunway, Selangor, Malaysia. binaya@nobelcollege.edu.np.
- Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.
- School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500, Sunway, Selangor, Malaysia.
- College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
ORCID-Profile: Binaya Sapkota, Subish Palaian, Sunil Shrestha, Mohamed Izham Mohamed Ibrahim
Förderung
- Monash University
Zitieren
APA
Sapkota, B., Palaian, S., Shrestha, S., & Ibrahim, M. I. M. (2023). Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System. Therapeutic Innovation & Regulatory Science, 57(4), 886-898. https://doi.org/10.1007/s43441-023-00514-4
Vancouver
Sapkota B, Palaian S, Shrestha S, Ibrahim MIM. Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System. Therapeutic Innovation & Regulatory Science. 2023;57(4):886-898. doi:10.1007/s43441-023-00514-4
BibTeX
@article{Sapkota2023,
author = {Sapkota, Binaya and Palaian, Subish and Shrestha, Sunil and Ibrahim, Mohamed Izham Mohamed},
title = {Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2023},
volume = {57},
number = {4},
pages = {886--898},
doi = {10.1007/s43441-023-00514-4}
}
EUVIMED